Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) announced the launch of a share repurchase program worth up to €50 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE